This phase 2 randomized clinical trial evaluates the effects of pazopanib in combination with paclitaxel vs paclitaxel and placebo on survival in patients with recurrent ovarian cancer.
http://ift.tt/2jU0Q28
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου